Browsing by Author Ginés Padrós, Silvia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)
20-Jul-2017A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease miceSuelves, Nuria; Kirkham-McCarthy, Lucy; Lahue, Robert S.; Ginés Padrós, Silvia
27-Nov-2014Description and Validation of New Therapeutical Targets to Prevent Neurodegenertlion and Cognitive Deficits in Huntington's DiseasePuigdellívol Cañadell, Maria del Mar
6-Jul-2018Dual role of CDK5 on cognitive deficits and striatal vulnerability in Huntington’s diseaseAlvarez Periel, Elena
12-Oct-2017Early Environmental Enrichment Enhances Abnormal Brain Connectivity in a Rabbit Model of Intrauterine Growth RestrictionIlla, Miriam; Brito, Verónica; Pla, Laura; Eixarch Roca, Elisenda; Arbat Plana, Ariadna; Batallé, Dafnis; Muñoz Moreno, Emma; Crispi Brillas, Fàtima; Udina, Esther; Figueras Retuerta, Francesc; Ginés Padrós, Silvia; Gratacós Solsona, Eduard
19-Jul-2010Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de HuntingtonPaoletti Rubia, Paola
23-Jul-2018Evaluation of therapeutic targets for the treatment of behavioral alterations and neuropathology in Huntington’s disease. The role of histone deacetylase 3 and p75 neurotrophin receptorSuelves Caballol, Núria
8-Feb-2016Metabolic profiling for the identification of Huntington biomarkers by on-line solid-phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis toolsPont Villanueva, Laura; Benavente Moreno, Fernando J. (Julián); Jaumot Soler, Joaquim; Tauler Ferré, Romà; Alberch i Vié, Jordi; Ginés Padrós, Silvia; Barbosa Torralbo, José; Sanz Nebot, María Victoria
9-Mar-2000Multifuncionalidad de la adenosina desaminasa de superficie y de sus proteínas de uniónGinés Padrós, Silvia
6-Dec-2006Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism.Toro, Daniel del; Canals i Coll, Josep M.; Ginés Padrós, Silvia; Kojima, Masami; Egea Guri, Gustavo; Alberch i Vié, Jordi
2-Sep-2014Neurotrophin receptor p75NTR mediates Huntington's disease-associated synaptic and memory dysfunctionBrito, Verónica; Giralt Torroella, Albert; Enriquez-Barreto, Lilian; Puigdellívol, Mar; Suelves, Nuria; Zamora-Moratalla, Alfonsa; Ballesteros, Jesús J.; Martín, Eduardo D.; Dominguez-Iturza, Nuria; Morales, Miguel; Alberch i Vié, Jordi; Ginés Padrós, Silvia
5-Jan-2016p75NTR in Huntington's disease: beyond the basal gangliaBrito, Verónica; Ginés Padrós, Silvia
11-Jul-2017Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease modelsDaldin, Manuel; Fodale, Valentina; Cariulo, Cristina; Azzollini, Lucia; Verani, Margherita; Martufi, Paola; Spiezia, Maria Carolina; Deguire, Sean M.; Cherubini, Marta; Macdonald, Douglas; Weiss, Andreas; Bresciani, Alberto; Vonsattel, Jean-Paul Gerard; Petricca, Lara; Marsh, J. Lawrence; Ginés Padrós, Silvia; Santimone, Iolanda; Marano, Massimo; Lashuel, Hilal A.; Squitieri, Ferdinando; Caricasole, Andrea
30-May-2017Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model.Giralt Torroella, Albert; Brito, Verónica; Chevy, Quentin; Simonnet, Clémence; Otsu, Yo; Cifuentes Díaz, Carmen; Pins, Benoit de; Coura, Renata; Alberch i Vié, Jordi; Ginés Padrós, Silvia; Poncer, Jean Christophe; Girault, Jean Antoine
2005Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregationWang, Jin; Ginés Padrós, Silvia; MacDonald, Marcy E.; Gusella, James F.
15-Jan-2016Study of mitochondrial dysfunction mechanisms in Huntington's disease striatal degenerationCherubini, Marta